Postgraduate

Pharmacy MPhil, PhD, MD

Pharmacy MPhil, PhD, MD

MPhil - full time: minimum 12 months, part time: minimum 24 months
PhD - full time: minimum 36 months, part time: minimum 72 months
MD - full time: normally 24 months, part time: normally 48 months

Profile

We have scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy. This spans the fundamental understanding and concepts of drug action, the discovery of new drugs and development of medicines, the clinical management and rationale use of medicines, through to the professional role of the pharmacist in improving public health.


Your programme during COVID-19

Please rest assured we make all reasonable efforts to provide you with the programmes, services and facilities described. However, it may be necessary to make changes due to significant disruption, for example in response to COVID-19.

Further information

Our COVID-19 Study page gives more information about your Newcastle University study experience.

Terms and conditions and student complaints

The University has terms and conditions which create a positive environment for learning and academic achievement.

Given the changing nature of the COVID-19 pandemic, the commitments outlined are subject to the guidelines that may be in place at the time.


Our research areas

As a postgraduate research student studying for an MPhil or PhD, you will be based within the School of Pharmacy  If your research involves clinical components there may be a partnership with the NHS.

The School of Pharmacy's focus is on multidisciplinary translational research, work that is relevant to real life.

We offer MPhil and PhD supervision in the following research areas:

Disease-Selective Medicines

The discovery and development of new small molecule therapeutics with improved disease selectivity and reduced systemic toxicities, through the use of rational drug design and synthesis, lead optimisation, and preclinical evaluation in cellular disease model systems. We are particularly interested in the development of cancer prodrugs with tumour specific activation and reduced systemic toxicity, and novel therapies for improved treatment of infective diseases including Dengue and other haemorrhagic fever viruses and Tuberculosis, amongst others.

Improved Strategies for the Treatment of Chronic Pain

Understanding the molecular mechanisms that generate and maintain the symptoms and processes of chronic pain, and its translation to effective strategies for pain control, including opioid treatment.

Cellular Physiology

Understanding the pathways that allow hormones to control epithelial ion channel activity and physiological action, particularly the control of sodium channel activity in the distal nephron and consequent hypo/hyper-tension.

Safety Pharmacology and Discovery Toxicology

Development and utilisation of new preclinical tools for identification of therapeutics with potential safety liabilities, particularly novel clinically relevant cell models and systems for detection of effects upon the heart.

Pharmaceutics and Chemical Principles of Dosage Form Design

Pharmaceutical formulations to deliver active molecules to treat disease. We have active research on intermolecular interactions, nanoscale pharmaceutics and nanotherapeutics, including dosage form design from intermolecular interactions, and delivery of biopharmaceuticals. In particular research is focused on:

  • determining strategies for improving drug solubility and altering materials properties to enable effective drug delivery and the production of enhanced medicines.
  • supramolecular Pharmaceutics, particularly inter/intramolecular interactions and kinetics leading to, during and after self-assembly of small organic molecules.
  • fundamental and translational nanomedicines
  • understanding and improving drug delivery via the subcutaneous, inhaled and intravitreal routes of delivery

Pharmaceutical Public Health

The role of community pharmacy as a central fulcrum to address health inequalities and behaviour change in relation to smoking, alcohol and substance misuse, sexual health and obesogenic behaviours, amongst others. As the community pharmacy is the most frequent point of contact for patients and public within the wider primary healthcare team, we evaluate the dynamics and interactions of this relationship and the potential role for pharmacy within the early diagnosis of disease and improvements in public health.

Rational Medicines Use

The safe and efficient use of medicines in primary and secondary care is central to the role of every pharmacist. However, medicines are becoming increasingly complex and patients are being given more preventative medicine focused at improving their health, which poses clear risks and significant potential for complications. Rationalisation of medicine usage crosses care boundaries, applies both within primary and secondary care, and furthermore at the care interface. We investigate prescribing habits and the mechanisms to support patients who may take complex medicines for a significant portion of their life

Patient Safety and Health Information Technology

Medication errors can result in patient injury or death, and are preventable. These errors can occur at the stages of ordering, transcription, dispensing and administration. We conduct studies around key technological advances targeted towards intercepting these errors and improving patient safety. Our research focuses on evaluation of specific health information technology prevention strategies throughout the medication use process, with a particular emphasis on health information technology, including its broader implications for medical care and policy. We also explore the different types and causes of errors that occur during the prescribing process when using electronic systems, providing national and international recommendations for their improvement.

Quality and Ranking

We rank in the top 100 for  Life Sciences and Medicine - QS World University Rankings by Subject 2020

Related Degrees

  • Drug Delivery and Nanomedicine MRes

    Our Drug Delivery and Nanomedicine MRes is a research-based course with a taught component. It provides a springboard into a career that involves a working knowledge of scientific research.

  • Toxicology MRes

    The MRes is a research-based course with a taught component. It provides a springboard into a career that involves a working knowledge of scientific research.

All related programmes

Training & Skills

You will receive a tailored package of support from the University to ensure you maximise your research and future career. There are also opportunities to undertake your research at Newcastle within a Doctoral Training Centre, Centre for Doctoral Training or Doctoral Training Partnership.

Faculty of Medical Sciences Research Student Development Programme

Our Research Student Development Programme is a community made up of postgraduates from the Faculty of Medical Sciences.

It supports your research whilst developing your professional skills and confidence.

You will make an on-going assessment of your own development and training needs through personal development planning (PDP) in the ePortfolio system. Our organised external events and development programme have been mapped against the Vitae Researcher Development Framework to help you identify how best to meet your training and development needs.

Doctoral training centres and partnerships

Being part of a Doctoral Training Partnership (DTP), Doctoral Training Centre (DTC) or Centre for Doctoral Training (CDT) means that you can benefit from the research expertise and training of a number of leading universities, academic schools and academics. You'll also be studying alongside a cohort of other PhD students.

These centres are often interdisciplinary, combining expertise and training from multiple subject areas. You may also be able to collaborate with an industrial or commercial organisation.

Your PhD will be funded. Normally the fees are covered and you'll receive a tax-free stipend or living expenses. Additional funding is sometimes available to cover things such as conference attendance and research materials.

The centres/ partnerships below may have PhD opportunities available in your subject area.

Fees & Funding

2021-2022 fees

If your studies last longer than one year your fee may be subject to an annual inflationary increase.

The fees displayed here are per year.

MPhil, PhD, MD

Home

Full time: £4,407 - £15,607*
Part time: £2,203.50 - £7,803.50*

*The fees given above are for 2020-21 only. For 2021-22 entry, we will be aligning our standard Home research fees with those set by UK Research and Innovation (UKRI). The standard fee will be confirmed in Spring 2021 by UKRI. 

International

Full time: £24,000 - £35,500

Find out more about our tuition fees, including how to pay them and available discounts.

Fee ranges

Our fee range takes into account your research topic and resource requirements.

Your research topic is unique and as such will have unique resource requirements. Resources could include specialist equipment, such as laboratory/workshop access, or technical staff.

If your research involves accessing specialist resources then you're likely to pay a higher fee. You'll discuss the exact nature of your research project with your supervisor(s). You'll find out the fee in your offer letter.

Funding opportunities

Entry Requirements

MPhil

A 2:1 honours degree, or international equivalent, in a science or medicine related subject.

PhD

A 2:1 honours degree, or international equivalent. Further research experience or a master’s degree would be advantageous.

MD

A MBBS, or an equivalent medical degree.

Find out the equivalent qualifications for your country.

Use the drop down above to find your country. If your country isn't listed please email: international.recruitment@ncl.ac.uk for further information.

English Language Requirements

To study this course you need to meet the following English Language requirements:

IELTS 6.5 overall (with a minimum of 5.5 in all other sub-skills).

Our typical English Language requirements are listed as IELTS scores but we also accept a wide range of English Language tests.

You may need an ATAS (Academic Technology Approval Scheme) clearance certificate. You'll need to get this before you can get your visa or study on this programme. We'll let you know about the ATAS requirement in your offer letter.

How to Apply

You apply online, track your application and contact the admissions team via our applicant portal. Our step-by-step guide can help you on your way.

You do not need to identify a supervisor prior to submitting your application via the applicant portal.

As part of your application, please upload a short (non-binding) research proposal to indicate your broad area of interest (outline any proposed methods if applicable). This helps us assess both your suitability for a research degree and whether we can offer supervision.

If your application is successful and we can match you with a supervisor, you will normally be invited to attend a selection interview (either on campus, by video-conferencing or Skype).

Start dates

There are usually three possible start dates, although in some circumstances an alternative start date can be arranged:

  • January
  • April
  • September

There is no application closing date for this course, but specific deadlines for funding may apply.

We suggest international students apply at least two months before the course starts. This is so that you have enough time to make the necessary arrangements.

Deposit

If you live outside the UK/EU you must:

  • pay a deposit of £1,500
  • or submit an official letter of sponsorship

The deposit is payable after you receive an offer to study at Newcastle University. The deposit is non-refundable, but is deducted from your tuition fees when you register.

Contact

UK/EU students should contact:
Postgraduate Coordinator
Medical Sciences Graduate School
Telephone: +44 (0) 191 208 7002
Email: medpg-enquiries@ncl.ac.uk

International students wishing to discuss these opportunities may contact:
Andrea Wadham
International Recruitment Manager
Faculty of Medical Sciences
Telephone: +44 (0) 191 208 4841 
Email: biomed-international-pg@ncl.ac.uk

Connect with us

Downloads